ConductScience.org, home

Paper8448115

Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding.

Satyanarayana S and 2 others. Biochemistry, 1993. Cited by 558 papers, by iCite.

Cite this record

ConductScience Library. Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. Papers, record 8448115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8448115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding.
PubMed
Journal
Biochemistry
PubMed
Year
1993
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
558
iCite
Relative citation ratio, by iCite
21.6
iCite
Revised in PubMed
2019-06-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Satyanarayana SS
2Dabrowiak JCJ C
3Chaires JBJ B

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNAMajor topic
Intercalating AgentsMajor topic
Organometallic CompoundsMajor topic
PhenanthrolinesMajor topic
RutheniumMajor topic
Binding Sites
Circular Dichroism
Ferricyanides
Isomerism
Kinetics
Nucleic Acid Denaturation
Spectrometry, Fluorescence
Spectrophotometry
Structure-Activity Relationship
Viscosity

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA35635NCI NIH HHSUnited StatesR01CA035635PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by94

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 558 citations.

PMIDTitleJournalYearIn PapersSource
39992325Effect of 6,6-Substitution on 2,2'-Bipyridine and Probing Biomolecular Interaction Through Experimental and Computational Studies Towards Anticancer Potency.J Fluoresc2025https://conductscience.org/library/papers/39992325PubMed
39811293Towards targeted cancer therapy: Synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2'-dipyridylamine metal complex.Heliyon2025https://conductscience.org/library/papers/39811293PubMed
39031237An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects.J Fluoresc2025https://conductscience.org/library/papers/39031237PubMed
38613713Synthesis and Characterization of Zn(II) Complex of 4-chloro-2-(((2-phenoxyphenyl)imino)methyl)phenol and its Biological Efficacies: DNA Interaction, ADMET, DFT and Molecular Docking Study.J Fluoresc2025https://conductscience.org/library/papers/38613713PubMed
38602589Application of Novel Ruthenium (II) Polypyridyl Complexes as Robust DNA Probes, Optical Material and Antimicrobials-An Experimental and DFT Approach.J Fluoresc2025https://conductscience.org/library/papers/38602589PubMed
38393498
Synthesis of Novel [{(2-Amino-5-Nitro-N-[(E)-Thiophen-2-yl-Methylidene]Aniline-κ3N1:N4:S)(Sulphato-κ2O1:O3)}Zinc(II)] Complex with Physico-Chemical and Biological Perspective Exploration: A Combined Experimental and Computational Studies.
J Fluoresc2025https://conductscience.org/library/papers/38393498PubMed
37867880Synthesis, structural characterization, antioxidant, cytotoxic activities and docking studies of schiff base Cu(II) complexes.Heliyon2023https://conductscience.org/library/papers/37867880PubMed
37705997Deciphering the binding mechanism of an anti-cancer phytochemical plumbagin with calf thymus DNA using biophysical and in silico techniques.Front Chem2023https://conductscience.org/library/papers/37705997PubMed
37477757Interactions of arene ruthenium(II) complexes [η6-(C6H6)Ru(pprip)Cl]+ and [η6-(C6H6)Ru(H2iiP)Cl]+ with RNA triplex poly(U)•poly(A)*poly(U).J Biol Inorg Chem2023https://conductscience.org/library/papers/37477757PubMed
35936428
Heterodinuclear Ru-Pt Complexes Bridged with 2,3-Bis(pyridyl)pyrazinyl Ligands: Studies on Kinetics, Deoxyribonucleic Acid/Bovine Serum Albumin Binding and Cleavage, In Vitro Cytotoxicity, and In Vivo Toxicity on Zebrafish Embryo Activities.
ACS Omega2022https://conductscience.org/library/papers/35936428PubMed
35744808DNA Interaction, DNA Photocleavage, Photocytotoxicity In Vitro, and Molecular Docking of Naphthyl-Appended Ruthenium Complexes.Molecules2022https://conductscience.org/library/papers/35744808PubMed
35540910An investigation on 3-acetyl-7-methoxy-coumarin Schiff bases and their Ru(ii) metallates with potent antiproliferative activity and enhanced LDH and NO release.RSC Adv2018https://conductscience.org/library/papers/35540910PubMed
35530785
Seven membered chelate Pt(ii) complexes with 2,3-di(2-pyridyl)quinoxaline ligands: studies of substitution kinetics by sulfur donor nucleophiles, interactions with CT-DNA, BSA and in vitro cytotoxicity activities.
RSC Adv2019https://conductscience.org/library/papers/35530785PubMed
35492083Binuclear and tetranuclear Zn(ii) complexes with thiosemicarbazones: synthesis, X-ray crystal structures, ATP-sensing, DNA-binding, phosphatase activity and theoretical calculations.RSC Adv2020https://conductscience.org/library/papers/35492083PubMed
35353277A Biophysical Study of Ru(II) Polypyridyl Complex, Properties and its Interaction with DNA.J Fluoresc2022https://conductscience.org/library/papers/35353277PubMed
34833864Biological Activity of Triazolopyrimidine Copper(II) Complexes Modulated by an Auxiliary N-N-Chelating Heterocycle Ligands.Molecules2021https://conductscience.org/library/papers/34833864PubMed
34770744Antimicrobial and Anticancer Application of Silver(I) Dipeptide Complexes.Molecules2021https://conductscience.org/library/papers/34770744PubMed
34350537Antiproliferative and antibacterial properties of biocompatible copper(II) complexes bearing chelating N,N-heterocycle ligands and potential mechanisms of action.Biometals2021https://conductscience.org/library/papers/34350537PubMed
34200469Photoinduced DNA Cleavage and Photocytotoxic of Phenanthroline-Based Ligand Ruthenium Compounds.Molecules2021https://conductscience.org/library/papers/34200469PubMed
33468203Comprehensive understanding of the effects of metallic cations on enzymatic hydrolysis of humic acid-pretreated waste wheat straw.Biotechnol Biofuels2021https://conductscience.org/library/papers/33468203PubMed

See all 94 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8448115

GET https://conductscience.org/api/papers/v1/8448115/cited_by?page=2